ERJ Open Research

Article	Citations
The long-term effects of insulin use in incident cystic fibrosis-related diabetes: a target trial emulated using longitudinal national registry data	182
BreathEase: rationale, design and recruitment of a randomised trial and embedded mixed-methods study of a multiprofessional breathlessness service in early palliative care	84
Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients	66
Dysglycaemia among tuberculosis patients without known diabetes in a low-endemic setting	53
A survey of UK respiratory specialists’ opinion on the management of chronic cough	52
Dual CFTR modulator therapy efficacy in the real world: lessons for the future	51
Long-term incident severe outcomes in a prospective cohort of non-obese obstructive sleep apnoea patients free of comorbidities at inclusion	43
Comparison of two scores for short-term outcomes in patients with COPD exacerbation in the emergency department: the Ottawa COPD Risk Scale and the DECAF score	43
Supplementary oxygen efficacy for chronic pulmonary disorders and exertion desaturation	42
Period and cohort effects: consequences on spirometric lung function in Norway during the 20th century	40
Williams–Campbell syndrome case series and discordant twins	40
Extracellular iron and the lung microbiome in smoking and Chronic Obstructive Pulmonary Disease	39
Diagnostic delay in bronchiectasis: an Italian perspective	38
Targeted DNase treatment of obstructive lung disease: a pilot randomised controlled trial	34
“Patients at risk of nontuberculous mycobacterial pulmonary disease who need testing evaluated using a modified Delphi process by European experts.” Michael R. Loebinger, Stefano Aliberti, Charles Haw	33
The noninvasive ventilation outcomes score in patients requiring NIV for COPD exacerbation without prior evidence of airflow obstruction	30
The impact of personal and outdoor temperature exposure during cold and warm seasons on lung function and respiratory symptoms in COPD	29
Global survey of physician testing practices for nontuberculous mycobacteria	29
ROHHAD syndrome in an adult: presence of ZSCAN1 antibodies	28
Myostatin/Smad2/Smad3 pathway define a differential clinical phenotype in COPD-associated sarcopenia	28
The Role of Clamping Before Removal of a Chest Tube in Post-Surgical and Pneumothorax Patients Using Digital Drainage Systems: A Non-inferiority Randomized Trial	28
Managing breathlessness for people with advanced respiratory disease	27
The NEUROCOUGH Chronic Cough Registry: A protocol for a pan-European observational study	27
Predicting clinical exacerbations using respiratory oscillometry during home telemonitoring of patients taking medium/high dose asthma treatment	27
Increased delay to lung transplantation for women candidates: gender-based disparity matters in the lung transplant trajectory	27

Dendritic cells in the lung cavities of XDR-TB patients exhibit altered frequency and phenotype	27
Achieving adherence to positive airway pressure in commercial drivers using an employer-mandated remote management programme	26
Prevalence and consequences of patient-ventilator interactions in a cohort of home ventilated restrictive and neuromuscular patients. A multicenter study	26
Diagnosis of pulmonary embolism in patients with haemoptysis: the POPEIHE study	26
Triple therapy in COPD: understanding the data	25
Corticosteroid therapy in fibrotic interstitial lung disease: a modified Delphi survey	25
A comprehensive evaluation of murine and humanex vivocultured alveolar macrophages	25
Antitrypsin deficiency: still more to learn about the lung after 60 years	25
Influence of sex, season and environmental air quality on experimental human pneumococcal carriage acquisition: a retrospective cohort analysis	25
A double-blind randomised placebo-controlled trial investigating the effects of lesogaberan on the objective cough frequency and capsaicin-evoked coughs in patients with refractory chronic cough	24
Proteins associated with preserved ratio impaired spirometry	24
Anodal transcranial direct current stimulation over the right primary somatosensory cortex increases cough reflex sensitivity: a pilot randomised controlled crossover trial	24
High-frequency percussive ventilation in acute respiratory failure	24
Spirometry at different Latin American altitudes: a Global Lung Function Initiative project	23
Shape of the association between endotoxin in school dust and children's lung-function	23
Increased loop gain and upper airway collapsibility among smoking patients with obstructive sleep apnoea	23
Inhaled corticosteroids and COVID-19 outcomes in asthma: the Israeli experience	23
Reflecting real-world patients with mesothelioma in research: an interim report of baseline characteristics from the ASSESS-meso cohort	22
Prevalence and types of treatable traits in bronchiectasis: a multicentre, cross-sectional study	22
An observational study ofPseudomonas aeruginosain adult long-term ventilation	21
Clinical impact of routine sleep assessment by peripheral arterial tonometry in patients with COPD	21
Differential cardiopulmonary haemodynamic phenotypes in PASC-related exercise intolerance	21
Utility of rehabilitation prior to bronchoscopic lung volume reduction:post hocanalysis of the VENT trial	21
ERS International Congress 2022: highlights from the Basic and Translational Science Assembly	21
Association of patient-reported outcome measures with lung function and mortality in fibrotic interstitial lung disease: a prospective cohort study	20
Moderate-to-severe ARDS: COVID-19 patients compared to influenza patients for ventilator parameters and mortality	20
Role of bronchoscopy for respiratory involvement in granulomatosis with polyangiitis and microscopic polyangiitis	20
Artificial intelligence augmentation raises questions about the future of bronchoscopy	20
Increasing airway obstruction through life following bronchopulmonary dysplasia: a meta-analysis	20
To burn or not to burn: similar effects of different types of prenatal tobacco exposure on infant lung function	19
Respiratory infections after elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis: analysis of the European Cystic Fibrosis Society Patient Registry	19
Effects of seasonality and treatment on COPD clinical outcomes: IMPACTpost hocanalysis	19
Uncontrolled asthma from childhood to young adulthood associates with airflow obstruction	19
Navigating family dynamics and ethical considerations in genetic diagnosis of pulmonary arterial hypertension: insights from in-depth semi-structured interviews	19
Prednisolone for COPD exacerbations: time for a rethink	19
Chaotic breathing in post-COVID-19 breathlessness: a key feature of dysfunctional breathing can be characterised objectively by approximate entropy	18
Still no room to breathe: insights on supine lung mechanics from oscillometry in COPD	18
Alpha-1-Antitrypsin deficiency and increased risk of atrial fibrillation in two large population-based cohorts	18
Association of DPP-4 inhibitors with respiratory and cardiovascular complications in patients with COPD: a nationwide cohort study	18
Developing a self-management package for pulmonary fibrosis: an international Delphi study	18
Clinical assessment of balance and functional impairments in people with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis	18
Should all patients with COPD be treated with inhaled triple therapy?	18
Associations of physical activity and quality of life in parapneumonic effusion patients	18
Time to negative conversion and cardiopulmonary performance in athletes with COVID-19	18
Impact of targeted pulmonary arterial hypertension therapies in severe pulmonary hypertension in chronic lung diseases	18
Evaluation of a screening protocol for telomere biology disorders in individuals with interstitial lung disease undergoing lung transplant evaluation	17
Interstitial lung abnormalities: do symptoms matter?	17
Changes in fatigue symptoms following an exercise-based rehabilitation programme for patients with long COVID	17
A robust web-based tool to predict viral shedding in patients with Omicron SARS-CoV-2 variants	17
Right ventricular–pulmonary arterial coupling predicts mortality in precapillary pulmonary hypertension	17

Oxygen saturation targets for children with respiratory distress: a systematic review	17
Detection of pulmonary hypertension in idiopathic pulmonary fibrosis using random forest models and automated measures of central CT structures	17
Optimal treatment of the underlying aetiology is the most effective antimicrobial stewardship for chronic respiratory disease: a lesson learned from cystic fibrosis	17
Long-term follow-up after bronchoscopic lung volume reduction valve treatment for emphysema	17
Home sleep studies in children with neurodisabilities: success rates and parental perception	17
Mepolizumab has clinical benefits including oral corticosteroid sparing irrespective of baseline EGPA characteristics	16
A worldwide look into long COVID-19 management: an END-COVID survey	16
Deleterious effect ofPseudomonas aeruginosaon F508del-CFTR rescued by elexacaftor/tezacaftor/ivacaftor is clinical strain-dependent in patient-derived nasal cells	16
Sleep and cardiometabolic comorbidities in the obstructive sleep apnoea–COPD overlap syndrome: data from the European Sleep Apnoea Database	16
Plasma sphingolipids, lung function and COPD: the Cardiovascular Health Study	16
Modifiable lifestyle risk factors for sarcoidosis: a nested case–control study	16
Risk factors, molecular analysis and treatment outcomes of amikacin-resistant Mycobacterium avium complex pulmonary disease	15
The impact of anti-eosinophilic therapy on exercise capacity and inspiratory muscle strength in patients with severe asthma	15
Pulmonary artery wedge pressure and left ventricular end-diastolic pressure during exercise in patients with dyspnoea	15
An adjudication algorithm for respiratory-related hospitalisation in idiopathic pulmonary fibrosis	15
Comorbidities reduce survival and quality of life in COPD with severe lung hyperinflation	15
“You can do it yourself and you can do it at your convenience”: internet accessibility and willingness of people with chronic breathlessness to use an internet-based breathlessness self-management int	15
Is overreliance on short-acting β2-agonists associated with health risks in the older asthma population?	15
Hospitalisation outcomes in pneumococcal-vaccinatedversus-unvaccinated patients with exacerbation of COPD: results from the HOPE COPD Study	15
How to distinguish PPI-refractory from PPI-responsive patients in gastro-oesophageal reflux-induced chronic cough: post-reflux swallow induced peristaltic wave index and mean nocturnal baseline impeda	15
Effect of water- and land-based exercise on lung function in children with post-COVID-19 condition: secondary results from a randomised controlled trial	15
Intimal granulomatous angiitis in sarcoid pulmonary vasculitis: worth remembering	14
Phase I dose-escalation study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of an inhaled recombinant human ACE2	14
Safety and feasibility of ultrathin probe transbronchial lung cryobiopsy without balloon blockerviarobotic bronchoscopy in the evaluation of peripheral lung lesions: a retrospective pilot study	14
Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries	14
Persistent tachypnoea of infancy and neuroendocrine cell hyperplasia of infancy: from systematic review to future directions	14
Persistence of a SARS-CoV-2 T-cell response in patients with long COVID and lung sequelae after COVID-19	14
Arterial remodelling in smokers and in patients with small airway disease and COPD: implications for lung physiology and early origins of pulmonary hypertension	14
Increased bronchiectasis risk and related risk factors in inflammatory bowel disease: a 10-year Korean national cohort study	14
Biomarkers of chronic airflow limitation and COPD identified by mass spectrometry	14
Demographic and clinical characteristics of patients with α1-antitrypsin deficiency genotypes PI*ZZ and PI*SZ in the Spanish registry of EARCO	14
Pulmonary fibrosis in patients with autoimmune pulmonary alveolar proteinosis: a retrospective nationwide cohort study	14
External validation of the OPALS prediction model for in-hospital mortality in patients with acute decompensated pulmonary hypertension	14
Breathing pattern and muscle activity using different inspiratory resistance devices in children with mouth breathing syndrome	14
Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis	14
Sputum microbiome α-diversity is a key feature of the COPD frequent exacerbator phenotype	14
Dupilumab-associated hypereosinophilia in severe asthma	14
“Influence of physical activity on the prognosis of COPD patients: the HADO.2 score – health, activity, dyspnoea and obstruction”. Cristóbal Esteban, Nere Larrea, Amaia Aramburu, Javier Moraza, Leyre	13
It is time to end our love affair with short-acting β2-agonists in asthma? Yes	13
Reply: Key role of dysregulated airway epithelium in response to respiratory viral infections in asthma	13
Next-generation sequencing reveals genetic heterogeneity and resistance mechanisms in patients withEGFR-mutated non-small cell lung cancer treated with afatinib	13
Priming mucosal pathogen-agnostic innate immunity with an intranasal TLR2/6 agonist in an aged population	13
ERS Congress 2024: highlights from the Basic and Translational Sciences Assembly	13
Circulating biomarkers and progression of idiopathic pulmonary fibrosis: data from the INMARK trial	13
Shared genetic risk factors: implications for treatment of idiopathic pulmonary fibrosis and systemic hypertension	13
Infant lung function: criteria for selecting tidal flow–volume loops	13
Untargeted metabolomic analysis reveals different metabolites associated with response to mepolizumab and omalizumab in asthma	13
Predictors of mortality and hospitalised exacerbations in obstructive airway diseases	13
Benefit−risk assessment of brensocatib for treatment of non-cystic fibrosis bronchiectasis	13
COVID-19 in patients with pulmonary alveolar proteinosis: a European multicentre study	13
Possible overdiagnosis of early-stage lung adenocarcinoma among never-smokers in Taiwan	13
The impact of the COVID-19 pandemic on pleural infection incidence: a UK multicentre retrospective analysis	13
Patients at risk of nontuberculous mycobacterial pulmonary disease who need testing evaluated using a modified Delphi process by European experts	13
De-labelling severe asthma diagnosis: the challenge of DIPNECH	13
Compartment-specific protein interactions in beryllium lung disease	13
A systematic review with meta-analysis of biomarkers for detection of pulmonary arterial hypertension	12
The feasibility of implementing clinical decision support system software in the outpatient assessment of breathlessness: Cardio-LungHealth and Everton in the Community	12
Cardiac dysfunction during exercise in young adults with bronchopulmonary dysplasia	12
A focus group study about healthcare professionals’ perspectives on patient education in pulmonary rehabilitation	12
Communicating with patients with idiopathic pulmonary fibrosis: can we do it better?	12
Biomarkers of type 2 inflammation as predictors of response to biologics for severe eosinophilic asthma	12
No effect of danazol treatment in patients with advanced idiopathic pulmonary fibrosis	12
Effects of exercise and a lifestyle app on sleep disordered breathing, physical health and quality of life	12
Rapid real-world implementation of pulmonary telerehabilitation: good fortune or COVID-19 luck?	12
Shorter walk test durations to detect ambulatory oxygen desaturation in interstitial lung disease: an observational cohort study	12
Acute effects of low dose bisoprolol on lung function and blood pressure in COPD patients	12
Evaluation of spirometry-gated computed tomography to measure lung volumes in emphysema patients	12
Upper-lobe CT imaging features improve prediction of lung function decline in COPD	12
Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges	12
Acknowledging the syndemic: A real-life cohort study on major adverse cardiovascular events in COPD	12
Severe pulmonary hypertension–interstitial lung disease presenting as right ventricular failure: stabilisation with intravenous prostacyclin and maintenance with inhaled prostacyclin	12
Exercise responses and mental health symptoms in COVID-19 survivors with dyspnoea	11
Current and novel treatment options for obstructive sleep apnoea	11
“A pulmonary rehabilitation shared decision-making intervention for patients living with COPD: PReSent: protocol for a feasibility study”. Amy C. Barradell, Linzy Houchen-Wolloff, Noelle Robertson, Hi	11
Natural variability of lung function in primary ciliary dyskinesia: longitudinal analysis from the PROVALF-PCD cohort	11
Gene expression profile of epithelial–mesenchymal transition in tumours of patients with nonsmall cell lung cancer: the influence of COPD	11
The effect of exacerbations on lung density in α1-antitrypsin deficiency	11
Efficacy of interventions to alter measures of fat-free mass in people with COPD: a systematic review and meta-analysis	11
Longitudinal change in ultrasound-derived rectus femoris cross-sectional area in COPD	11
Immunoprofiling bronchoalveolar lavage cells reveals multifaceted smoking-associated immune dysfunction	11

ERS Congress 2024: highlights from the Clinical Techniques, Imaging and Endoscopy Assembly	11
Lower airway clinical outcome measures for use in primary ciliary dyskinesia research: a scoping review	11
Early benefit of mepolizumab on small airways in severe asthma: insights from the IMPOSE study	11
An exploration of clinically meaningful definitions of cough bouts	11
Lung disease in never smokers with severe alpha-1 antitrypsin deficiency: The EARCO Registry	11
The association of weather conditions with day-to-day variability in physical activity in patients with COPD	11
Diffuse panniculitis in a teenage male with ZZ α1-antitrypsin deficiency	11
Upper-limb intervalversusconstant-load exercise in patients with COPD: a physiological crossover study	11
Telemonitoring for the follow-up of home noninvasive ventilation: a promising future with ongoing challenges	11
Predictors of invasive mechanical ventilation use in patients with acute decompensated pulmonary hypertension admitted to the intensive care unit	11
Insights from the INSIGHTS-ILD Registry: real-world heterogeneity in treatment patterns for patients with fibrotic interstitial lung disease	11
Risk factors and interventions for developing recurrent pneumonia in older adults	11
Age and body mass index affect fit of spirometry Global Lung Function Initiative references in schoolchildren	11
Home is where spirometry should be; enhancing care for individuals with pulmonary fibrosis	11
ERS International Congress 2022: highlights from the Interstitial Lung Diseases Assembly	11
OSA symptom subtypes and hypoxic burden independently predict distinct cardiovascular outcomes	10
Factors most strongly associated with breathlessness in a population aged 50–64 years	10
High-flow oxygen therapyversusnoninvasive ventilation: a randomised physiological crossover study of alveolar recruitment in acute respiratory failure	10
Laboratory and free-living gait performance in adults with COPD and healthy controls	10
Response to endobronchial valve treatment: it's all about the target lobe	10
Circadian variability in breath volatiles is affected by the timing of inhaled corticosteroids in asthma	10
Systemic pro-inflammatory response following bronchoscopic lung volume reduction using endobronchial valves	10
Influence of age in the assessment of therapeutic response in patients with pulmonary arterial hypertension	10
Feasibility of using continuous positive airway pressureviathe LeVe CPAP System among children with acute hypoxaemic respiratory failure at Mengo Hospital, Kampala, Uganda: a mixed-methods stud	10
Noninvasive diagnosis of pulmonary hypertension with hyperpolarised129Xe magnetic resonance imaging and spectroscopy	10
Locus of control and breathlessness: a cross-sectional analysis of 28 730 people	10
Measuring spirometry in a lung cancer screening cohort highlights possible underdiagnosis and misdiagnosis of COPD	10
Obstructive sleep apnoea-related respiratory events and desaturation severity are associated with the cardiac response	10
Suppression of epithelial abnormalities by nintedanib in induced-rheumatoid arthritis-associated interstitial lung disease mouse model	10
Normal values of respiratory oscillometry in South African children and adolescents	10
Pulmonary Hypertension and Measurement of Exercise Capacity Remotely: Evaluation of the 1-min Sit-to-Stand Test (PERSPIRE) – a cohort study	10
Ciliary dyskinesia in severe asthma is not affected by chronic mucus hypersecretion	10
Living with chronic cough: experiences, burden and management in interstitial lung disease – a mixed methods study	10
Inhaled nitric oxide for the treatment of COVID-19: an open-label, parallel, randomised controlled trial	10
Symptomatic smokers without COPD have physiological changes heralding the development of COPD	10
Novel CFTR modulator combinations maximise rescue of G85E and N1303K in rectal organoids	10
Hypercoagulation in COPD: the clot thickens	10
Respiratory symptoms and their determinants in the general Spanish population: changes over 20 years	10
Activation of STAT3 in the COPD airway epithelium	10
The Palestinian primary ciliary dyskinesia population: first results of the diagnostic and genetic spectrum	10
Artificial intelligence improves bronchoscopy performance: a randomised crossover trial	10
The role of theADRB2Thr164Ile variant in lung function determination, plasma proteome variability and other phenotypes in UK Biobank	10
Physical capacity and inactivity in obstructive airway diseases: a “can do, do do” analysis	10
Post-viral lung diseases: the microbiota as a key player	9
The effects of dual IQOS and cigarette smoke exposure on airway epithelial cells: implications for lung health and respiratory disease pathogenesis	9
Exercise intolerance in post-coronavirus disease 2019 survivors after hospitalisation	9
Exhaled volatile organic compounds associated with risk factors for obstructive pulmonary diseases: a systematic review	9
Past asthma exacerbation in children predicting future exacerbation: a systematic review	9
Identification of Two Distinct Molecular Endotypes in Cough Variant Asthma Based on Sputum Transcriptomics and Clinical Pathophysiological Features	9
ERS International Congress 2023: highlights from the Respiratory Intensive Care Assembly	9
Post-pandemic seasonal dynamics of hospitalised COPD exacerbations and aetiologies in the COPD population	9
Endobronchial cryobiopsy may shorten the time to cancer diagnosis: a retrospective study	9
Hypercapnia is not excluded by normoxia in neuromuscular disease patients: implications for oximetry	9
Methicillin-resistant Staphylococcus aureus and pulmonary outcome in people with cystic fibrosis: a European Cystic Fibrosis Patient Registry data analysis	9
Utility of diaphragm dome height as a marker of operational lung volume changes, disease burden and exacerbations in patients with mild-to-moderate COPD: an observational study within the CanCOLD coho	9
Variability in P2X receptor composition in human taste nerves: implications for treatment of chronic cough	9
Venous thromboembolism associated with severe dyspnoea and asthma in 102 792 adults	9
Bronchiectasis: moving from an orphan disease to an unpleasant socioeconomic burden	9
Simultaneous measurement of inhaled air and exhaled breath by double multicapillary column ion-mobility spectrometry, a new method for breath analysis: results of a feasibility study	9
Delayed airway epithelial repair is correlated with airway obstruction in young adults born very preterm	9
Performance of two portable exhaled nitric oxide fraction devices compared to a “gold standard” chemiluminescence device	9
Adverse perception of cough in patients with severe asthma: a discrete choice experiment	9
Airflow obstruction among young adults in Europe: A Chronic Airway Diseases Early Stratification (CADSET) collaboration with 48 612 individuals across eight population-based cohorts	9
Validation and Cross-Cultural Insights of the French Translation of the Severe Asthma Questionnaire	9
A cystic and bullous lung disease associated with a PIK3CA-related overgrowth syndrome	9
Utility of adding oesophageal to endobronchial endosonography when staging lung cancer: a randomised trial	9
Does COVID-19 vaccination increase the risk of interstitial lung disease at a population level?	9
Breathomics in controlled asthma: identification of nonanoic and propanoic acids as volatile organic compounds	9
Telemedicine and virtual respiratory care in the era of COVID-19	9
Clinical significance of respiratory bacteria and mycobacteria isolates in adult bronchiectasis in Taiwan	9
Chronic noninvasive ventilation in COPD; towards the identification of a responder phenotype	9
Assessment of factors and interventions towards therapeutic adherence among persons with non-cystic fibrosis bronchiectasis	9
Effects of acetazolamide on sleep disordered breathing in pulmonary vascular disease: a randomised controlled trial	9
ERS Congress 2024: highlights from the Respiratory Intensive Care Assembly	9
Predicting outcomes after hospitalisation for COPD exacerbation using machine learning	9
Poor performance of paired tests of latent tuberculosis in highly immune-compromised individuals exposed to multidrug-resistant tuberculosis: time for new diagnostic markers	9
Beyond type 2 asthma biomarkers: risk stratification for NSAID-exacerbated respiratory disease	9
BOS-318 treatment enhances elexacaftor–tezacaftor–ivacaftor-mediated improvements in airway hydration and mucociliary transport	9
Peeping at COPD through the keyhole: time to broaden the view to the complexity of the disease by the heterogeneity of symptoms	9
Open-source, three-dimensionally printed manifolds for exposure studies using human airway epithelial cells	8
COVID-19 and its continuing burden after 12 months: a longitudinal observational prospective multicentre trial	8
Real-world comparative effectiveness of biologic therapies in severe asthma: EU-ADVANTAGE	8
Endothelial to mesenchymal transition is an active process in smokers and patients with early COPD contributing to pulmonary arterial pathology	8
Treatable traits in chronic cough: a prospective evaluation for predicting cough persistence	8
NSAID-exacerbated respiratory disease: a population study	8
Self-help cognitive behavioural therapy for anxiety in pulmonary hypertension: pilot randomised controlled trial	8
Subcutaneous octreotide as a therapeutic option for refractory chronic cough: subjective response pattern and adverse effects from a retrospective single-centre case series	8
ERS International Congress 2022: highlights from the Respiratory Intensive Care Assembly	8
Non-pharmacological interventions for inducible laryngeal obstruction: a thematic analysis towards a standardised approach	8
Two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist	8
European Respiratory Society clinical practice guidelines: methodological guidance	8
Anti-IL-4Rα aptamer reduces IL-4 signalling and formation of nasal polyps	8
Multiomics links global surfactant dysregulation with airflow obstruction and emphysema in COPD	8
The impact of seat height on 1-min sit-to-stand test performance in COPD: a randomised crossover trial	8
Severe pulmonary hypertension associated with lung disease is characterised by a loss of small pulmonary vessels on quantitative computed tomography	8